Financial News
Latest News about XNAS:RVNC
Recent news which mentions XNAS:RVNC
RVNC DEADLINE ALERT: Revance Therapeutics Investors Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on March 4, 2025
February 17, 2025
Tickers
RVNC
REVANCE THERAPEUTICS INVESTOR ALERT: Kaplan Fox Alerts Investors of a Class Action Deadline on March 4, 2025
February 15, 2025
Tickers
RVNC
RVNC SHAREHOLDER ALERT: Deadline to Lead in Securities Fraud Lawsuit Against Revance Therapeutics, Inc. (RVNC) is March 4, 2025 - Contact Kaplan Fox
February 14, 2025
Tickers
RVNC
Kaplan Fox Alerts Revance Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is March 4, 2025
February 13, 2025
Tickers
RVNC
RVNC DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC) and Lead Plaintiff Deadline on March 4, 2025
February 12, 2025
Tickers
RVNC
Tickers
RVNC
RVNC DEADLINE FOR LEADERSHIP is March 4, 2025 in a Securities Fraud Lawsuit - Contact Kaplan Fox
February 01, 2025
Tickers
RVNC
Tickers
RVNC
REVANCE THERAPEUTICS DEADLINE FOR LEADERSHIP is March 4, 2025 in a Securities Fraud Lawsuit - Contact Kaplan Fox & Kilsheimer LLP
January 30, 2025
Tickers
RVNC
RVNC DEADLINE: Investors of Revance Therapeutics, Inc. Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on March 4, 2025
January 29, 2025
Tickers
RVNC
Kaplan Fox Alerts Revance Therapeutics, Inc. (RVNC) Investors to a Securities Class Action Lawsuit - Deadline is March 4, 2025
January 13, 2025
Tickers
RVNC
RVNC DEADLINE: Investors Are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on March 4, 2025
January 11, 2025
Tickers
RVNC
RVNC Deadline to Lead in Securities Fraud Lawsuit is March 4, 2025 - Contact Kaplan Fox & Kilsheimer LLP
January 10, 2025
Tickers
RVNC
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
